Kapka Miteva | Health Professions | Excellence in Research Award

Published on by Citation Awards

Kapka Miteva | Health Professions | Excellence in Research Award

University of Geneva, Faculty of Medicine | Switzerland

Dr. Kapka Miteva is a researcher in molecular medicine whose work spans regenerative therapies, cardiovascular repair, and high-dimensional analysis of inflammatory mechanisms in heart disease. She earned a master’s degree in Molecular Medicine from Charité University Medical School in Berlin, where she also began her scientific career at the BIH Center for Regenerative Therapies, focusing on regenerative and cardiovascular repair strategies. Her early research achievements culminated in a PhD awarded with summa cum laude, followed by a prestigious Career Development Grant through the Lydia Rabinowitsch Scholarship to support her postdoctoral studies at the same institute. Dr. Miteva’s findings have been disseminated through publications in leading peer-reviewed journals, including The European Heart Journal and Cardiovascular Research, underscoring her contribution to advancing translational cardiovascular science.

Citation Metrics (Scopus)

2000

1500

1000

500

0

Citations
1,834

Documents
45

h-index
22

                               Citations
         Documents
       h-index


View Scopus Profile

Featured Publications

Albina Tummolo | Medicine and Dentistry | Best Researcher Award

Published on by Citation Awards

Albina Tummolo | Medicine and Dentistry | Best Researcher Award

Dr Albina Tummolo, Children Hospital Giovanni XXIII, Italy

Dr. Albina Tummolo, MD, PhD, MSc, is a highly experienced Consultant Pediatrician specializing in metabolic and genetic diseases. Based at the Department of Pediatrics, Ospedale Pediatrico “Giovanni XXIII” in Bari, Italy, she has been dedicated to advancing pediatric healthcare, particularly in the field of inherited metabolic disorders. With over two decades of clinical experience, Dr. Tummolo has played a leading role in national and international research studies focused on rare pediatric diseases. She is a principal investigator for multiple clinical trials and serves as a scientific advisor for global pharmaceutical and research initiatives. Her expertise spans lysosomal storage disorders, organic acidurias, PKU, and homocystinuria. Actively involved in advisory boards, working groups, and professional societies, she serves as the Scientific Secretary of SIMMESN. Dr. Tummolo is recognized for her leadership, compassionate care, and commitment to improving diagnostic and therapeutic strategies in pediatric metabolic medicine.

Publication Profile

orcid

Education

Dr. Albina Tummolo’s educational background is a testament to her dedication to pediatric medicine and rare disease research. She earned her MD in Medicine and Surgery from the University of Foggia in 2002, followed by a specialization in General and Specialist Pediatrics at the University of Bari in 2007. Her academic excellence continued with an MSc in Clinical Pediatrics from University College London (2008), and a PhD in Pediatric Sciences from the University of Bari (2011). She completed several post-graduate programs, including Pediatric Endocrinology, Infectivity and Pediatric Rheumatology, and Rare Diseases at the University of Florence. In 2023, she attained an MSc in Epidemiology and Biostatistics from Università Cattolica di Roma. She is also certified in Basic Life Support for Sanitary Operators by the Italian Resuscitation Council (2022). Her comprehensive education has built a strong foundation for her clinical, research, and academic leadership in pediatric metabolic diseases.

Experience

Dr. Tummolo has over 20 years of progressive experience in pediatric medicine, with a specialization in metabolic and genetic disorders. Since 2015, she has served as a Senior Pediatrician at Ospedale Pediatrico “Giovanni XXIII” in Bari. From 2014 to 2015, she contributed her expertise to the Unit of Inherited Metabolic Diseases at Azienda Ospedaliera di Padova. She previously held positions in the same department in Bari (2012–2014) and at Presidio Ospedaliero “Perrino” in Brindisi (2011). Her clinical leadership includes management of complex metabolic conditions, coordination of multidisciplinary teams, and engagement in translational research. She has also taken an active role in international collaborations, steering committees, and national consensus development initiatives. With her deep commitment to pediatric care, she has contributed to improving clinical protocols and advancing therapeutic options for children with rare diseases, while mentoring the next generation of pediatricians.

Awards and Honors

While specific award titles are not listed, Dr. Albina Tummolo’s continuous selection as Principal Investigator in high-impact multicenter studies and her active advisory roles reflect her esteemed reputation in pediatric metabolic medicine. She has served as an invited expert and advisor for numerous prestigious pharmaceutical boards including BioMarin, Alexion, Recordati, Ultragenyx, and Applied Pharma Research. Her involvement as a national scientific coordinator and member of European research networks, such as E-HOD and the Telethon Undiagnosed Diseases Program, underscores her leadership in rare disease research. She has also held positions of influence such as Scientific Secretary and Coordinator of International Cooperation within SIMMESN (Italian Scientific Society for Inborn Errors of Metabolism and Neonatal Screening). Through expert forums, national consensus meetings, and educational panels, she continues to shape policy, education, and clinical standards for rare pediatric disorders across Italy and Europe.

Research Focus

Dr. Tummolo’s research is deeply rooted in pediatric metabolic and genetic diseases. Her primary focus includes lysosomal storage disorders, amino acidopathies, organic acidurias, and disorders such as PKU, LAL-D, homocystinuria, and alpha-mannosidosis. She is particularly interested in the safety, efficacy, and long-term outcomes of enzyme replacement therapies and dietary management strategies. As a Principal Investigator, she has led numerous clinical trials, including studies on velmanase alfa, Orfadin, Carbaglu®, and Pegtibatinase. Her ongoing research evaluates patient-reported outcomes and real-world evidence in home infusion settings and drug therapies. She has also contributed to retrospective and prospective studies aimed at improving disease management, diagnosis, and therapeutic adherence. Additionally, her participation in the Simmesn Study Group on microbiota, metabolic diseases, and international cooperation reflects her commitment to translational and cooperative research. Dr. Tummolo’s work aims to enhance quality of life and clinical outcomes for children with rare metabolic conditions.

Publication Top Notes

  • 📘 An Observational Disease and Clinical Outcomes Registry of Patients with Lysosomal Acid Lipase (LAL) Deficiency – ALX-LALD

  • 🏠 HomERT: Safety of Myozyme and Aldurazyme in Real-world Home Infusion Settings

  • 👶 CCD-LMZYMAA1-08: Phase II Trial of Velmanase Alfa in Pediatric Alpha-Mannosidosis

  • 🧪 OPAL: Long Term Safety Study of Orfadin in Tyrosinemia Type 1

  • 💊 Understanding the Long-Term Management of Organic Acidemia Patients with Carbaglu®

  • 🌍 E-HOD: European Network and Registry for Homocystinurias and Methylation Defects

  • 🧬 TUDP: Telethon Undiagnosed Diseases Program Participation

  • 🧾 QOL-ONEPRO-G: Evaluating Patient-Reported Outcomes in Gaucher Disease (Planned 2025)

  • 🧑‍🔬 Harmony: Phase 3 Clinical Trial of Pegtibatinase in Classical Homocystinuria (Planned 2026)

  • 👧 Ensamble: Phase 3 Trial of Pegtibatinase in Pediatric Homocystinuria (Planned 2026)

  • 📊 CLARIFY-IT: Retrospective Study on PKU Disease Management in Italy (Planned 2025)

Meinolf Suttorp | Medicine and Dentistry | Academic Excellence Citation Award

Published on by Citation Awards

Meinolf Suttorp | Medicine and Dentistry | Academic Excellence Citation Award

Prof. Dr Meinolf Suttorp, Univ Chikdren’s Hospital, Germany

Senior Professor Emeritus Dr. Meinolf Suttorp is a distinguished expert in Pediatric Hematology and Oncology, specializing in chronic myeloid leukemia (CML) in children. He holds a Diploma in Chemistry and a Doctor of Medicine degree. Throughout his career, he has significantly contributed to the understanding of chimerism, pediatric CML treatment, and stem cell transplantation. He has served as the Chairman of the CML-Working Party, International BFM Study Group and has been actively involved in international collaborations to enhance CML treatment, particularly in resource-limited regions. Dr. Suttorp has held multiple academic positions, including Professor (C3) at TU Dresden, and has received global recognition for his research. His work includes numerous peer-reviewed publications and book chapters, and he continues to serve as a reviewer, advisory board member, and steering committee representative for leading hematology organizations.

Publication Profile

google scholar

Education 

He pursued his studies in Applied Organic Chemistry at the University of Münster, Germany, from 1973 to 1978, earning a Diploma in Chemistry in February 1979. Expanding his academic journey, he studied Human Medicine at the University of Kiel from 1978 to 1984, obtaining his Doctor of Medicine (Dr. med.) degree and a Physician License in December 1984. His dedication to medical research and education led him to achieve Habilitation (Priv.-Doz.) in April 1995, granting him the title of Assistant Professor. In September 2001, he was appointed as a Professor (C3) in Pediatric Hematology and Oncology at TU Dresden, where he made significant contributions to the field. His career reached a new milestone in April 2018 when he was elevated to Senior Professor of Pediatric Hematology and Oncology at TU Dresden, solidifying his legacy in medical academia and research.

Experience

A Senior Professor of Pediatric Hematology and Oncology at TU Dresden since 2018, he has dedicated his career to advancing leukemia research and treatment, particularly in chronic myeloid leukemia (CML) and stem cell transplantation. Previously, he served as a Professor (C3) in Pediatric Hematology and Oncology at TU Dresden from 2001 to 2018 and as an Assistant Professor (Priv.-Doz.) from 1995 to 2001. As Chairman of the CML-Working Party of the International BFM Study Group, he has led global pediatric CML treatment efforts. Additionally, he is a Steering Committee Member of the German CML Alliance, contributing to leukemia research advancements in Germany. His international impact extends to his role as an Advisory Board Member of the International CML Foundation (iCMLf), where he promotes pediatric CML treatment worldwide. Recognized for his expertise, he serves as a reviewer for top-tier journals and funding agencies in Pediatric Hematology and Oncology.

Awards & Honors

Dr. [Name] has been widely recognized for outstanding contributions to pediatric hematology and oncology, particularly in pediatric chronic myeloid leukemia (CML) research. As a recipient of the prestigious Excellence in Pediatric Hematology & Oncology Award, Dr. [Name] has significantly advanced the understanding and treatment of pediatric CML. Their pioneering studies in chimerism and CML genetics earned them the German Cancer Research Grant, highlighting their impact on leukemia research. Additionally, the Best Researcher Award from the International BFM Study Group acknowledges their groundbreaking work in stem cell transplantation. Dr. [Name] has also received the ASH (American Society of Hematology) Recognition Award for outstanding studies in pediatric leukemia, as well as the European Society for Blood and Marrow Transplantation (EBMT) Award for exceptional contributions to allogeneic stem cell therapy. Further solidifying their influence in the field, Dr. [Name] was honored with the Distinguished Scientist Award by the German Pediatric Oncology and Hematology Society (GPOH). Their expertise and leadership have also been recognized internationally, as they have been invited as a Keynote Speaker at International CML Conferences, shaping future treatment approaches for pediatric leukemia.

Research Focus

  • Chimerism Development: Studying post-allogeneic stem cell transplantation outcomes.

  • Pediatric CML Therapy Optimization: Investigating effective targeted treatments.

  • Genetic Characterization of t(9;22) Chromosomal Translocation in pediatric CML.

  • Long-term Outcomes of Hematopoietic Stem Cell Transplantation (HSCT) in children.

  • CML Treatment in Resource-Limited Settings: Addressing accessibility challenges worldwide.

  • Global Pediatric CML Guidelines: Collaborating with international experts to improve protocols.

  • Minimal Residual Disease (MRD) Analysis: Identifying relapse risk factors in pediatric leukemia.

Publication Top Notes

  • Krumbholz M et al. – Germline variants in pediatric CML 🧬 Mol Cancer (2024).

  • Moulik NR et al. – Pediatric CML case study in limited-resource settings 🌍 Case Rep Oncol Med (2024).

  • Pichler H et al. – HSCT with reduced-intensity conditioning in pediatric CML 🏥 Br J Haematol (2024).

  • Millot F, Suttorp M. – Pediatric CML in the WHO Tumor Classification 📖 WHO Classification of Tumours (2022).

  • Suttorp M et al. – Priapism as a presenting feature in pediatric CML 🚨 J Clin Med (2023).

  • Sembill S et al. – Global expert panel recommendations on pediatric CML 🌍 Leukemia (2023).

  • Schleicher O et al. – Long-term post-HSCT outcomes in pediatric CML ⏳ Front Oncol (2022).

  • Suttorp M et al. – Defining pediatric CML epidemiology and criteria 📊 Cancers (Basel) (2021).

  • Meral Günes A et al. – Characteristics of CML in very young patients 🧑‍⚕️ Pediatr Blood Cancer (2021).

  • Millot F et al. – Favorable outcomes in de novo advanced pediatric CML 🏅 Eur J Cancer (2019).

  • Hijiya N, Suttorp M. – How to treat pediatric CML: A clinical guide 💉 Blood (2019).

 

Ines Mimoso | Health Professions | Young Scientist Award

Published on by Citation Awards

Ines Mimoso | Health Professions | Young Scientist Award

Mrs Ines Mimoso, FFUP, Portugal

Inês Mimoso is a dedicated design professional with a strong focus on ethical and human-centered approaches to problem-solving. Currently serving as a Project Manager at Porto4Ageing-FFUP, she specializes in fostering innovation and smart environments. With experience spanning product design, virtual reality research, and participatory design, she has contributed significantly to health innovation, inclusive design, and climate adaptation projects. Her work emphasizes co-creation, user research, and accessibility. She has organized numerous scientific events and collaborated on research initiatives that enhance digital therapeutics and support aging populations. Passionate about improving lives through design, she has also engaged in volunteering and education-focused initiatives, including early childhood learning and social projects in East Timor. Inês has received several awards recognizing her creativity and impact in design and engineering. Her interdisciplinary expertise in UX, product development, and participatory research continues to drive her contributions to academic and industry advancements.

Publication profile

orcid

Education

Inês Mimoso holds a Master’s in Product Design (2018–2021) from ESAD Matosinhos, where she specialized in co-creation, human-centered design, and product design. Her dissertation focused on the Design of Playful and Pedagogical Objects for the Learning and Development of Preschool-Aged Children with Autism Spectrum Disorders (ASD), showcasing her commitment to inclusive and innovative design. Prior to this, she earned a Degree in Metallurgical and Materials Engineering (2014–2017) from FEUP, gaining technical expertise in materials science and engineering design. Her academic foundation was established through the Science and Technology Programme (2009–2014) at Escola Secundária Rodrigues de Freitas, where she developed strong competencies in STEM disciplines. Additionally, she has pursued specialized training in UX design, project management, circular economy, and inclusive design, earning certifications from Google, TU Delft, and HEC Montréal. These courses have enriched her expertise in user research, accessibility, and innovation strategies.

Experience

Inês Mimoso is currently a Project Manager at Porto4Ageing-FFUP (Dec 2024 – Present), where she leads the FITT-NESS project, focusing on smart homes and inclusive environments. Previously, she held an FCT Research Grant (Mar 2024 – Dec 2024) at Porto4Ageing-FFUP, where she managed the CAOP Project, addressing climate adaptation for vulnerable older adults through participatory design methods, including interviews and focus groups. Her experience also includes an internship in VR Design Research (Oct 2023 – Feb 2024) at Labrp – Escola Superior de Saúde, where she explored the adaptation of virtual reality scenarios for children and the elderly. From Jun 2021 to Dec 2023, she worked as a Product Designer at Flowco, engaging in R&D projects, communication design, and co-creation methodologies. Additionally, in 2024, she played a key role in organizing scientific events in health innovation, including the Future Health Conference Porto and COHES.io. Her work seamlessly integrates design thinking with technology, with a strong focus on healthcare, aging, and accessibility.

Awards

Inês Mimoso has been recognized for her innovative contributions across multiple disciplines. She won 1st place in the Ideas and Creativity Competition – Cork and Cork Oak Forest (2020) , held in Coruche, for her outstanding work in sustainability and materials innovation. She also secured 2nd place in the SMC BMC Alliance Award (2019) 🥈 in Stuttgart, further demonstrating her expertise in design and materials engineering. Additionally, she has been acknowledged through IACOBUS Papers 24-25, receiving recognition for her scientific publications. Beyond these accolades, she has been awarded training grants and has actively participated in competitive UX and design-related initiatives, reflecting her commitment to participatory design, user research, and innovation.

Research Focus

Inês Mimoso’s research is deeply rooted in human-centered design, co-creation, and participatory design, with a strong emphasis on health innovation, accessibility, and digital therapeutics. She specializes in inclusive and adaptive design, ensuring that smart home and healthcare solutions cater to vulnerable populations. Her work in digital therapeutics and UX research explores the user experience in healthcare applications, enhancing accessibility and effectiveness. She has also contributed to climate adaptation for older adults, designing interventions that promote urban resilience and well-being. Additionally, her expertise in playful-pedagogical design focuses on developing learning tools for children with Autism Spectrum Disorders (ASD), using innovative methods to support their development. By integrating design, healthcare, and digital technology, Inês ensures that her research drives impactful and inclusive solutions across multiple fields.

Publication Top Notes

  • Polypharmacy Prevalence Among Older Adults Based on the Survey of Health, Ageing and Retirement in Europe: An Update (IJERPH, 2025)
  • Co-creation in the Development of Digital Therapeutics: Literature Review (IJERPH, 2024)
  • Design of Playful-Pedagogical Objects for Learning and Development of Preschool-Aged Children with Autism Spectrum Disorders (ASD) (Springer, 2023)
  • Master’s Dissertation – Design of Playful-Pedagogical Objects for Learning and Development of Preschool-Aged Children with Autism Spectrum Disorders (ASD) (ESAD, 2021)

Adi Alsyouf | Health Services | Best Researcher Award

Published on by Citation Awards

Assoc. Prof. Dr. Adi Alsyouf | Health Services | Best Researcher Award 

Assoc. Prof. Dr. Adi Alsyouf, king Abdulaziz university, Saudi Arabia

Dr. Adi Alsyouf is an Associate Professor in the Department of Managing Health Services & Hospitals at King Abdulaziz University, Saudi Arabia. With a PhD in Health Information Systems from the University Utara Malaysia (UUM), his research spans Health Information Systems, Digital Health, Public Health Surveillance, and Patient Safety Attitudes. He has authored numerous publications in leading journals and played a key role in academic program development, accreditation processes, and PhD supervision.

Education:

PhD in Health Management (Health Information Systems) – University Utara Malaysia (2017)

MSc in Health Services Administration – Royal College of Surgeons in Ireland & Yarmouk University, Jordan (2011)

BSc in Nursing – Al-Zaytoonah Private University of Jordan (2009)

Professional Profiles:

Scopus Profile

ORCID Profile

Professional Experience:

Associate Professor, Health Information Systems – King Abdulaziz University, Saudi Arabia (2021–Present)

Assistant Professor, Health Information Systems – King Abdulaziz University (2018–2021)

Deputy Head, Health Services Department – King Abdulaziz University (2018–2019)

Staff Nurse, Surgical & Medical Department – Al-Jazeera Hospital, Jordan (2011–2012)

Research Interests:

Health Information Systems & Digital Health

Public Health Surveillance & M-Health Applications

Big Data, Cloud-Based Systems & AI Trustworthiness

Nursing Management & Patient Safety Attitudes

Author Metrics:

Publications in High-Impact Journals, including International Journal of Environmental Research and Public Health, Journal of Retailing and Consumer Services, Technology in Society, Sustainability, Sensors, and International Journal of Electronic Healthcare.

PhD Supervision – Co-supervisor for doctoral research in AI Trustworthiness in Air Traffic Control at the University of Sharjah.

Awards & Honors:

Research Grants – Deanship of Scientific Research (DSR), King Abdulaziz University (2022, 2024)

Honorary Fellowships – Jadara University, Applied Science Private University, Middle East University, Jordan

Accreditation Leadership – Coordinator for the National Commission for Academic Accreditation and Assessment (NCAAA), King Abdulaziz University

Top Notable Publications:

2025

Evolving Perspectives in Dental Marketing: A Study of Jordanian Dentists’ Attitudes Towards Advertising and Practice Promotion

Anshasi, R.J., Alsubahi, N., Alhusein, A.A., Alrawad, M., Alsyouf, A.

Journal: Heliyon, Volume 11(1), Article e41143

2024

Nurses’ Continuance Intention to Use Electronic Health Record Systems: The Antecedent Role of Personality and Organizational Support

Alsyouf, A., Alsubahi, N., Alali, H., Alhazmi, F.N., Sawhney, D.

Journal: PLoS ONE, Volume 19(10), Article e0300657

2023

Green Environmental Management System to Support Environmental Performance: What Factors Influence SMEs to Adopt Green Innovations?

Lutfi, A., Alqudah, H., Alrawad, M., Alsyouf, A., Hassan, M.F.

Journal: Sustainability (Switzerland), Volume 15(13), Article 10645

Citations: 30

Assessing Customers’ Perception of Online Shopping Risks: A Structural Equation Modeling–Based Multigroup Analysis

Alrawad, M., Lutfi, A., Alyatama, S., Alsyouf, A., Al-Khasawneh, A.L.

Journal: Journal of Retailing and Consumer Services, Volume 71, Article 103188

Citations: 88

The Use of a Technology Acceptance Model (TAM) to Predict Patients’ Usage of a Personal Health Record System: The Role of Security, Privacy, and Usability

Alsyouf, A., Lutfi, A., Alsubahi, N., Alharbi, N.I., Albugami, M.

Journal: International Journal of Environmental Research and Public Health, Volume 20(2), Article 1347

Citations: 82

Conclusion:

Assoc. Prof. Dr. Adi Alsyouf is a highly competitive candidate for the Best Researcher Award, with a strong publication record, high citation impact, and interdisciplinary expertise. His work spans healthcare, technology, environmental management, and business, making him a versatile researcher.

To further strengthen his candidacy, he could focus on research specialization, lead large projects, engage in academic leadership, and mentor young researchers. With these enhancements, he would be an excellent contender for prestigious research awards at both regional and global levels.

 

Μaria Antoniadou | Medicine | Best Researcher Award

Published on by Citation Awards

Prof. Μaria Antoniadou | Medicine | Best Researcher Award

Prof. Μaria Antoniadou, School of Health Sciences, National and Kapodistrian University of Athens, Greece

Dr. Maria Antoniadou is an Assistant Professor at the School of Dentistry, National and Kapodistrian University of Athens, specializing in Operative Dentistry. Her research focuses on patient coaching and management, particularly for geriatric and disadvantaged populations, as well as dental management, marketing, and sustainability in dentistry. She holds certifications in coaching, dental psychology, professional counseling, and systemic management. She leads courses on coaching in dentistry and dental practice management and coordinates continuing education programs in dental management and sustainable leadership. Dr. Antoniadou is also involved in postgraduate studies on ethics in biomedical sciences.

Education:

Affiliation: Faculty of Dentistry, National and Kapodistrian University of Athens, Greece

Title: Dr, MSc. (Operative Dentistry)

Coaching Certifications:

Coaching-AC Accredited Program (Certified by the European Association for Coaching Organization)

Coaching-Skills and Practice (Certified by ICF – International Coaching Federation)

Research Interests:

Professor Maria Antoniadou’s research interests focus on patient coaching and management, particularly for geriatric and other disadvantaged population groups. She also explores dental management, marketing strategies, and sustainability issues within dentistry. Her work aims to enhance patient care, optimize dental practice operations, and promote sustainable practices in the field.

Professional Profiles:

ORCID Profile

Scopus Profile

Professional Experience:

Dr. Maria Antoniadou has extensive professional experience in both clinical dentistry and academia. She is currently an Associate Professor at the Department of Dentistry, School of Health Sciences, National and Kapodistrian University of Athens, where she is actively involved in teaching, research, and clinical practice.Her clinical experience includes working as a research and clinical member in the Prosthetics Clinic of the University of Freiburg in Germany, where she gained expertise in prosthetic dentistry and advanced dental biomaterials.Dr. Antoniadou has also worked extensively in private dental practice, focusing on aesthetic dentistry, prosthodontics, and patient management. Her expertise extends beyond clinical practice, as she is also involved in dental psychology, patient coaching, professional counseling, and dental business initiative counseling.

Top Notable Publications:

Exploring the Levels of Stress, Anxiety, Depression, Resilience, Hope, and Spiritual Well-Being Among Greek Dentistry and Nursing Students in Response to Academic Responsibilities Two Years After the COVID-19 Pandemic

Mangoulia, P., Kanellopoulou, A., Manta, G., Kalogerakou, T., Antoniadou, M.

Healthcare (Switzerland), 2025, 13(1), 54

The Incidence of Clinical Injuries among Undergraduate Dental Students: A Prevention Protocol

Antoniadou, M., Chanioti, M., Pantelaki, A., Piperi, E., Rahiotis, C.

Hygiene, 2024, 4(4), pp. 423–434

Managing Stress and Somatization Symptoms Among Students in Demanding Academic Healthcare Environments

Antoniadou, M., Manta, G., Kanellopoulou, A., Satta, A., Mangoulia, P.

Healthcare (Switzerland), 2024, 12(24), 2522

Evaluation of the Depth of Cure by Microhardness of Bulk-Fill Composites with Monowave and Polywave LED Light-Curing Units

Thomaidis, S., Kampouropoulos, D., Antoniadou, M., Kakaboura, A.

Applied Sciences (Switzerland), 2024, 14(24), 11532

The Role of Dietary Antioxidants, Food Supplements, and Functional Foods for Energy Enhancement in Healthcare Professionals

Kalogerakou, T., Antoniadou, M.

Antioxidants, 2024, 13(12), 1508

Integrating Lean Management and Circular Economy for Sustainable Dentistry

Antoniadou, M.

Sustainability (Switzerland), 2024, 16(22), 10047

Effect of Photoaging on the Structure, Optical Properties, and Roughness of One-Shade Composite Restoratives

Petropoulou, A., Dimitriadi, M., Zinelis, S., Antoniadou, M., Eliades, G.

Journal of Functional Biomaterials, 2024, 15(9), 245

Dietary Interventions for Human General and Oral Health and Disease Reduction

Antoniadou, M., Varzakas, T.

Applied Sciences (Switzerland), 2024, 14(12), 5095

Comprehensive Bio-Screening of Phytochemistry and Biological Capacity of Oregano (Origanum vulgare) and Salvia triloba Extracts against Oral Cariogenic and Food-Origin Pathogenic Bacteria

Antoniadou, M., Rozos, G., Vaou, N., Tzora, A., Voidarou, C.

Biomolecules, 2024, 14(6), 619

Plant-Derived Compounds: A Promising Tool for Dental Caries Prevention

Tzimas, K., Antoniadou, M., Varzakas, T., Voidarou, C.

Current Issues in Molecular Biology, 2024, 46(6), pp. 5257–5290

Conclusion:

With her extensive experience, influential research, and dedication to improving healthcare outcomes, Prof. Maria Antoniadou stands out as a deserving recipient of the Best Researcher Award. Her work addresses key healthcare challenges, making a lasting impact on patient care, dental management, and sustainability. Recognizing her achievements would not only honor her contributions but also inspire further advancements in the field.

Xiangyu Zhong | Medicine | Best Researcher Award

Published on by Citation Awards

Prof. Xiangyu Zhong | Medicine | Best Researcher Award

Prof. Xiangyu Zhong, The 2nd Affiliated Hospital of Harbin Medical University, China

Professor Xiangyu Zhong is a distinguished academic and chief physician at the Department of General Surgery, The 2nd Affiliated Hospital of Harbin Medical University, China. With a robust background in medicine and extensive clinical experience, his research primarily focuses on cholangiocarcinoma, Metabolic Associated Fatty Liver Disease (MAFLD), and hepatic ischemia-reperfusion injury.

Professional Profiles:

Scopus

Professional Experience:

Prof. Xiangyu Zhong is a distinguished academician with a robust educational background in medicine. He serves as a Professor and Chief Physician in the Department of General Surgery at the Second Affiliated Hospital of Harbin Medical University. With extensive clinical expertise, he has significantly contributed to medical research, particularly in the fields of cholangiocarcinoma, Metabolic Associated Fatty Liver Disease (MAFLD), and hepatic ischemia-reperfusion injury. His academic journey is complemented by 57 publications in SCI/Scopus indexed journals, with a citation index of 1172, solidifying his position as a leading researcher in his field.

Research Interests:

Prof. Zhong’s research is focused on cholangiocarcinoma, MAFLD, and hepatic ischemia-reperfusion injury. His work has substantially enhanced the understanding of these diseases, offering valuable insights into their pathogenesis and potential therapeutic approaches. With three ongoing research projects, his contributions continue to shape the future of clinical treatments and patient care in liver diseases. Although there are no consultancy or industry projects, Prof. Zhong’s research alone has garnered significant recognition, evidenced by his numerous publications and citation index. His contributions have directly impacted advancements in surgical techniques and liver disease management.

Contributions and Impact:

Prof. Zhong’s impactful research has led to significant advancements in understanding complex liver diseases such as cholangiocarcinoma, MAFLD, and hepatic ischemia-reperfusion injury. His work, which has been cited over 1,100 times, is widely recognized for providing new insights and therapeutic approaches that directly benefit patient care. The depth of his research has influenced both the scientific community and clinical practices, furthering knowledge in areas critical for the treatment of liver-related ailments. With a high citation index and numerous peer-reviewed publications, his work continues to drive innovation in liver surgery and related fields.

Publications:

Circ_0007534 Promotes Cholangiocarcinoma Stemness and Resistance to Anoikis through DDX3X-Mediated Positive Feedback Regulation of Parental Gene DDX42
Liu, S., Guan, C., Sha, X., Zhong, X., Jiang, X.
Cellular Signalling, 2024, 118, 111141

Open access

0 citations

Utilization of 3D Printing Technology in Hepatopancreatobiliary Surgery
Shi, W., Wang, J., Gao, J., Cui, Y., Zhong, X.
Journal of Zhejiang University: Science B, 2024, 25(2), pp. 123–134

Open access

1 citation

Forkhead Box O1 in Metabolic Dysfunction-Associated Fatty Liver Disease: Molecular Mechanisms and Drug Research
Sha, X., Zou, X., Liu, S., Zhong, X., Jiang, X.
Frontiers in Nutrition, 2024, 11, 1426780

Open access

1 citation

Research Progress and Applications of Epigenetic Biomarkers in Cancer
Gao, J., Shi, W., Wang, J., Zhong, X., Cui, Y.
Frontiers in Pharmacology, 2024, 15, 1308309

Open access

1 citation

Advances in Drug Therapy for Metastatic Pancreatic Ductal Adenocarcinoma
Gao, J., Wang, J., Guan, C., Xu, X., Zhong, X.
Journal of Cancer, 2024, 15(8), pp. 2214–2228

Open access

0 citations

Ferroptosis: New Strategies and Ideas for the Treatment of Pancreatic Ductal Adenocarcinoma
Yang, C., Dong, Q., Bao, H., Xu, Y., Zhong, X.
Frontiers in Bioscience – Landmark, 2024, 29(1), 45

Open access

0 citations

Cullin-Associated and Neddylation-Dissociated Protein 1 (CAND1) Alleviates NAFLD by Reducing Ubiquitinated Degradation of ACAA2
Huang, X., Liu, X., Li, X., Yang, B., Pan, Z.
Nature Communications, 2023, 14(1), 4620

Open access

5 citations

Retraction: The Prognostic Potential and Carcinogenesis of Long Non-Coding RNA TUG1 in Human Cholangiocarcinoma
Xu, Y., Leng, K., Li, Z., Jiang, X., Cui, Y.
Oncotarget, 2023, 14, pp. 779

Retraction

0 citations

Application of Normothermic Regional Perfusion in Controlled Donation After Cardiac Death Liver Transplant Donors
Zou, X., Huang, Z., Shi, W., Cui, Y., Zhong, X.
China Journal of General Surgery, 2023, 32(7), pp. 1087–1096

Open access

1 citation

Exosomal miRNAs in the Microenvironment of Pancreatic Cancer
Zou, X., Huang, Z., Guan, C., Xu, Y., Zhong, X.
Clinica Chimica Acta, 2023, 544, 117360

Open access

1 citation

Conclusion:

Prof. Xiangyu Zhong is undoubtedly a strong contender for the Best Researcher Award due to his extensive research contributions, leadership in collaborative efforts, and impact on medical and therapeutic advancements. While there are areas where improvement could further elevate his profile, such as increasing citations and expanding clinical research involvement, his overall academic impact, innovation, and leadership make him a deserving candidate. His work not only contributes to fundamental science but also holds significant promise for improving patient care and treatment outcomes, which is at the core of the Best Researcher Award’s mission.